Guro, Lilia P.

HRN: 27-93-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/11/2025
10/18/2025
IV
4.5G
Q8HRS
INFECTED ANTERIOR NECK MASS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: